{"groups":[{"description":"Epoetin Alfa will be administered 80,000 units subcutaneously every week beginning on Day 1. On Day 28, the dose was adjusted based upon patients' Hemoglobin Levels\n\nepoetin alfa: Epoetin alfa will be administered 80,000 u sc every week commencing on study day 1.","id":"FG000","title":"Epoetin Alfa - 80,000 U sc"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"31"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"31"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"From 9/2003 to 6/2008, a total of 31 patients were enrolled."}